Demiray, M. Et Al. 2005. The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report. Turkish Journal of Cancer , vol.35, no.1 , 19-25.

Demiray, M., EVRENSEL, T., Kanat, Ö., Kurt, E., ARSLAN, M., SARAYDAROĞLU, Ö., ... ERCAN, İ.(2005). The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report. Turkish Journal of Cancer , vol.35, no.1, 19-25.

Demiray, Mutlu Et Al. "The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report," Turkish Journal of Cancer , vol.35, no.1, 19-25, 2005

Demiray, Mutlu Et Al. "The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report." Turkish Journal of Cancer , vol.35, no.1, pp.19-25, 2005

Demiray, M. Et Al. (2005) . "The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report." Turkish Journal of Cancer , vol.35, no.1, pp.19-25.

@article{article, author={Mutlu Demiray Et Al. }, title={The efficacy of two different dosages of epirubicin in neoadjuvant setting: FEC50 v.s. FEC100. Preliminary report}, journal={Turkish Journal of Cancer}, year=2005, pages={19-25} }